Abstract: The present invention discloses the use of a semiconductor optical amplifier in a transceiver in order to increase the number of end users without reducing the bandwidth allocated to each user.

Abstract: This invention relates to the field of dye-sensitised solar cells (DSSC) and to a method for the low temperature platinisation of the counter-electrode which is applicable to a wide range of substrates.

Abstract: The present invention discloses a drug activator carrier comprising: a) particles having a metallic or metallic oxide core prepared from a paramagnetic material, said metallic core being coated with a coating material selected from polymer, metal or metal oxide; b) a biological material, having reductase activity, bound onto the metal coating the particles of step a), and wherein said biological material is capable of activating non-toxic pro-drugs into active and toxic drugs suitable for treating a disease; said drug activator carrier allowing targeted delivery of the toxic drug.

Abstract: The present invention discloses a synchronisation method suitable for increasing the receiving speed in the receiving part of an orthogonal optical frequency division multiplexing (OOFDM) transceiver.

Abstract: The present invention relates to the field of signal transmission using orthogonal optical frequency division multiplexing transceivers and to the use of the same set of wavelengths for the downlink and uplink signal transmission.

Abstract: The present invention discloses a haptic needle designed to be used as part of a medical training simulator.

Abstract: This invention relates to the field of dye-sensitized solar cells and discloses a method for reducing the temperature necessary for sintering the metal oxide paste coating the electrode.

Abstract: A method of preparing a compound of formula (III): wherein x is from 1 to 6, y is from 1 to 12, z is from 0 to 10, each M and each M? is independently a mycolic acid residue including a ?-hydroxy acid moiety and each S is a monosaccharide unit; the method comprising reacting one or more mycolic acids with one or more saccharide units wherein the hydroxyl group of each ?-hydroxy acid moiety is protected prior to reaction with the one or more saccharide units.

Abstract: Skin tissue measurement/treatment apparatus (40) for controllably delivering electromagnetic radiation having a frequency of 10 GHz or more directly to a localised region of skin tissue via a monopole antenna (44) adapted to penetrate the skin surface. One embodiment includes an applicator (152) having a plurality of independently controllable monopole antennas (158) protruding therefrom for selective treatment/measurement of an area of skin. Treatment may be activated based on the complex impedance of tissue in the localised region calculated by determined the magnitude and phase of reflected power relative to a reference signal. The power level of the generated electromagnetic radiation may be adaptively controlled based on the detection of net power delivered to the skin tissue.

Abstract: The present invention relates to the field of dye sensitised solar cell and to a method for preparing them rapidly and efficiently focussing on a rapid method for dye sensitisation.

Abstract: A compound of formula (I) for use in the treatment of a disease of the immune system; wherein R is an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 50 carbon atoms; R1 is an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 40 carbon atoms; each of R2, Wand R4 is independently selected from an optionally-substituted alkylene, alkenylene, alkynylene, arylene, arylalkylene or alkylarylene moiety having from 1 to 40 carbon atoms; each of X, Y and Z is independently selected from an optionally-substituted alkylene, alkenylene, alkenylene, arylene, alkylarylene, cycloalkylene, ketone, ester, amide, imide, imine, thioether, ether, thioester and thioketone; and P is selected from hydrogen, an alkyl group, a sugar residue, or a metal, phosphonium or ammonium species; wherein at least one of X, Y and Z includes a moiety selected from cyclopropyl, C=A, C-AH and C-OR5; wherein R5 is alkyl or haloalkyl, and A is O, S

Abstract: A compound of formula (I) for use as an adjuvant in vaccination; wherein R is an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 50 carbon atoms; R1 is an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 40 carbon atoms; each of R2, R3 and R4 is independently selected from an optionally-substituted alkylene, alkenylene, alkynylene, arylene, arylalkylene or alkylarylene moiety having from 1 to 40 carbon atoms; each of X, Y and Z is independently selected from an optionally-substituted alkylene, alkenylene, alkynylene, arylene, alkylarylene or cycloalkylene, ketone, ester, amide, imide, imine, thioether, ether, thioester, thioketone; and P is selected from hydrogen, an alkyl group, a sugar residue, or a metal, phosphonium or ammonium species; wherein at least one of X, Y and Z includes a moiety selected from cyclopropyl, C=A, C-AH and C—OR5; wherein R5 is alkyl or haloalkyl, and A is S, O or NR6, wherein R6

Abstract: A method of obtaining a solid component rich in a petroselinic compound from the seed of a plant of the Apiaceae or Araliaceae families, the method comprising: (a) treating a portion of the seed of the plant with an extraction solvent; and (b) inducing formation of the solid component.

Abstract: Apparatus (10) for treating skin tissue with microwave radiation (e.g. having a frequency of 1 GHz to 300 GHz) is disclosed in which an array of radiating elements (18), e.g. patch antennas are arranged on a flexible treating surface (16) for locating over and conforming with a region of skin tissue (24) to be treated. The radiating elements (18) receive microwave energy from a feed structure and are configured to emit outwardly a electromagnetic field which permits the region of skin to a substantially uniform penetration depth. Each radiating element (18) may have an independently controllable power supply to permit relative adjustment of the field across the treatment surface. Each radiating element may have a monitoring unit to allow adjust based on detected reflected power. Each independently controllable power supply may include a dynamic impedance matching unit.